PRE News and Press, Prenetics Global Limited From 02/02/23

LONDON and HONG KONG, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, today announced that its management team will participate virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference from ...

To ensure the company realizes the full potential of its broad genetics and digital testing platform and as a commitment to the EMEA market, Prenetics Globa ( NASDAQ: PRE ) names Dr. Bayju Thakar as CEO and shall join the board of directors for Prenetics EMEA, a wholly owned subsidiar...

LONDON and HONG KONG, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced an executive leadership change to ensure the company realizes the full potential of its broad genetics and digital testing platform and as a c...

3 Ways That Penny Stocks Can Make You Money in 2023 Penny stocks can also be a great way to make money if done correctly. Before you invest in a penny stock, it is important to do research into the company and understand how their stock works. This means understanding the risks associated wit...

Shares of Prenetics Global Limited (NASDAQ: PRE) were skyrocketing 27.8% higher as of 11:12 a.m. ET on Tuesday. The huge gain came after the company announced that the U.S. Food and Drug Administration (FDA) cleared ACT Genomics' ACTOnco comprehensive genomic profiling test for solid ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: ventdusud / Shutterstock.com We’re starting off the day with an overview of the biggest pre-market stock movers for Tuesday! Moving stocks this morning are acquisition deals, clinical trial data, a failed...

Prenetics Global ( NASDAQ: PRE ) said ACT Genomics received clearance from the U.S. Food and Drug Administration (FDA) for ACTOnco, the company's genomic profiling test for solid tumors. Prenetics noted that it had recently completed a majority stake acquisition of ACT Genomics. ...

Prenetics has completed the majority stake acquisition of ACT Genomics to spearhead its entry into to the US$80+ billion global precision oncology market FDA market authorization advances personalized cancer care in Asia Clearance sets the stage for continued R&D investment into early...

Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform Cancer genomics testing is now standard practice for cancer care and has shown to be highly successful such as Foundation One (acquired by Roche), Grail ...

LONDON and HONG KONG, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic and diagnostic testing, today announced that its board of directors has authorized a share repurchase program, and ...